Technology
Health
Medical

Nuvectra

$12.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.32 (2.59%) Today
+$0.32 (2.59%) Today

Why Robinhood?

You can buy or sell Nuvectra and other stocks, options, ETFs, and crypto commission-free!

About

Nuvectra Corporation Common Stock, also called Nuvectra, is a neurostimulation medical device company, which engages in the development and commercialization of neurostimulation technology platform for treatment of various disorders through stimulation of tissues associated with the nervous systems. It operates through Nuvectra segment. Read More The Nuvectra segment is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The company was founded on November 14, 2008 and is headquartered in Plano, TX.

Employees
200
Headquarters
Plano, Texas
Founded
2008
Market Cap
218.47M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
209.50K
High Today
$12.74
Low Today
$12.33
Open Price
$12.35
Volume
25.80K
52 Week High
$25.17
52 Week Low
$11.26

Collections

Technology
Health
Medical
2016 IPO
US
North America

News

MarketBeatMar 9

Stock Price, News, & Analysis for Nuvectra

Nuvectra Corporation, a neurostimulation medical device company, develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets.

3
Simply Wall StMar 8

What You Should Know About Nuvectra Corporation’s (NASDAQ:NVTR) Financial Strength

While small-cap stocks, such as Nuvectra Corporation (NASDAQ:NVTR) with its market cap of US$213m, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn.

29
Guru FocusMar 4

Nuvectra Corp (NVTR) Files 10-K for the Fiscal Year Ended on December 31, 2018

Nuvectra Corp (NASDAQ:NVTR) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Nuvectra Corp is a medical device company in the United States.

34

Earnings

-$1.16
-$0.99
-$0.82
-$0.65
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.